Scalp Cooling for Chemotherapy-Induced Alopecia in Breast Cancer: A Recent Literature Review

    Mochamad Rizki Hermawan, Rosliana Dewi, Dedi Wahyudin
    Studysummary This study reports that scalp cooling is 40%-90% effective in preventing chemotherapy-induced hair loss among breast cancer patients, particularly with taxane-based treatments, though some exhibited discontinuation due to mild side effects.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jurnal2.globalhealthsciencegroup.com →
    Discuss this study in the Community →